Literature DB >> 1187376

Ethionamide+cycloserine+pas vs isoniazid+streptomycin+pas in initial antiburerculosis chemotherapy followed by the standard regimen. A controlled study with special reference to the microscopic enumeration of bacillia as a criterion of efficacy.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1187376

Source DB:  PubMed          Journal:  Pneumonologie        ISSN： 0033-4073


× No keyword cloud information.
  26 in total

1.  [ETHIONAMIDE IN DOUBLE OR TRIPLE COMBINATION IN CHRONIC PRETREATED CAVERNOUS PULMONARY TUBERCULOSIS].

Authors:  I SCHUETZ; K BARTMANN
Journal:  Prax Pneumol       Date:  1964-05

2.  RETREATMENT OF PULMONARY TUBERCULOSIS IN PATIENTS WITH BACILLI RESISTANT TO MAJOR DRUGS. OPTIMAL REGIMENS.

Authors:  M ZIERSKI
Journal:  Bull Int Union Tuberc       Date:  1964-09

3.  [Modifications of the populations of tuberculous foci during antibacillary chemotherapy].

Authors:  G CANETTI
Journal:  Ann Inst Pasteur (Paris)       Date:  1959-07

4.  Cicatricial and cleaned out healing of tuberculous cavity of the lung and its impedimenta.

Authors:  S OKA; C SUZUKI; T KUROBANE; S SATO; S AWATAGUCHI; Y NIITSU; H UETA; M ICHINOMIYA; M SHOJI; H ASHIZAWA; H ISHIDA
Journal:  Sci Rep Res Inst Tohoku Univ Med       Date:  1958-03

5.  Clinical results of rifampicin treatment.

Authors:  C Virchow; J Flemming
Journal:  Antibiot Chemother       Date:  1970

6.  Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy.

Authors:  A W Lees; G W Allan; J Smith; W F Tyrrell; R J Fallon
Journal:  Tubercle       Date:  1971-09

7.  [Monotherapy of chronic pulmonary tuberculosis using Rimactan. Report on a 3-month-long therapeutic series].

Authors:  F Hofmann
Journal:  Schweiz Med Wochenschr       Date:  1968-09-07

8.  [Current status of chemotherapy for pulmonary tuberculosis in Finland].

Authors:  J Pätiälä; P Tani
Journal:  Prax Pneumol       Date:  1971-11

9.  Control clinical trial with rimactane in fresh, untreated cases of pulmonary tuberculosis.

Authors:  R Viswanathan; P U Rao; M Dusaj; D K Sarkar; U S Bhakta
Journal:  Indian J Med Res       Date:  1970-04       Impact factor: 2.375

10.  [Cooperative controlled trial of thiocarlide (DATC), PAS and bedrest alone in short-term single-drug treatment in retreated cavitary pulmonary tuberculosis].

Authors: 
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1969
View more
  1 in total

1.  A comparison of rifampicin, ethambutol or PAS in short-term monotherapy in pretreated cavitary pulmonary tuberculosis.

Authors: 
Journal:  Pneumonologie       Date:  1975-12-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.